These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Late-onset X-linked sideroblastic anemia following hemodialysis. Furuyama K, Harigae H, Kinoshita C, Shimada T, Miyaoka K, Kanda C, Maruyama Y, Shibahara S, Sassa S. Blood; 2003 Jun 01; 101(11):4623-4. PubMed ID: 12531813 [Abstract] [Full Text] [Related]
23. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine. Kucerova J, Horvathova M, Mojzikova R, Belohlavkova P, Cermak J, Divoky V. Acta Haematol; 2011 Jun 01; 125(4):193-7. PubMed ID: 21252495 [Abstract] [Full Text] [Related]
24. Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia. Kaneko K, Furuyama K, Fujiwara T, Kobayashi R, Ishida H, Harigae H, Shibahara S. Haematologica; 2014 Feb 01; 99(2):252-61. PubMed ID: 23935018 [Abstract] [Full Text] [Related]
25. A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia. Bekri S, May A, Cotter PD, Al-Sabah AI, Guo X, Masters GS, Bishop DF. Blood; 2003 Jul 15; 102(2):698-704. PubMed ID: 12663458 [Abstract] [Full Text] [Related]
27. Three kinships with ALAS2 P520L (c. 1559 C --> T) mutation, two in association with severe iron overload, and one with sideroblastic anemia and severe iron overload. Lee PL, Barton JC, Rao SV, Acton RT, Adler BK, Beutler E. Blood Cells Mol Dis; 2006 Jul 15; 36(2):292-7. PubMed ID: 16446107 [Abstract] [Full Text] [Related]
30. A Novel g.55040074delT in ALAS2 Gene Resulting in a Monomeric Protein and Severe Sideroblastic Anemia Phenotype. Bhatia P, Singh A, Hedge A. J Pediatr Hematol Oncol; 2017 Aug 15; 39(6):463-465. PubMed ID: 28731922 [Abstract] [Full Text] [Related]
34. Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation. Cazzola M, May A, Bergamaschi G, Cerani P, Ferrillo S, Bishop DF. Blood; 2002 Dec 01; 100(12):4236-8. PubMed ID: 12393718 [Abstract] [Full Text] [Related]
35. [Progress of study on sideroblastic anemia and its possible gene therapy--review]. Wang YQ, Zhu P. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun 01; 13(3):524-8. PubMed ID: 15972158 [Abstract] [Full Text] [Related]
37. Novel mutations in the ALAS2 gene from patients with X-linked sideroblastic anemia. Li J, Chen L, Lin Y, Ru K. Int J Lab Hematol; 2020 Aug 01; 42(4):e160-e163. PubMed ID: 32297424 [No Abstract] [Full Text] [Related]
38. X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley. Cotter PD, Rucknagel DL, Bishop DF. Blood; 1994 Dec 01; 84(11):3915-24. PubMed ID: 7949148 [Abstract] [Full Text] [Related]
39. Recent advances in the understanding of inherited sideroblastic anaemia. Camaschella C. Br J Haematol; 2008 Oct 01; 143(1):27-38. PubMed ID: 18637800 [Abstract] [Full Text] [Related]